PT2146713E - Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4- piridin-4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento de traumatismos cranianos - Google Patents

Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4- piridin-4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento de traumatismos cranianos Download PDF

Info

Publication number: PT2146713E
Authority: PT; Portugal
Prior art keywords: methoxy; oxido; dichloro; pyridin; carboxamide
Prior art date: 2007-04-19

Application number

PT08787960T

Other languages

English (en)

Portuguese (pt)

Inventor

Philippe Delay-Goyet

Corinne Perron

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-19

Filing date

2008-04-16

Publication date

2012-02-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38819821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2146713(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-04-16 Application filed by Sanofi Sa filed Critical Sanofi Sa

2012-02-07 Publication of PT2146713E publication Critical patent/PT2146713E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

PT08787960T 2007-04-19 2008-04-16 Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4- piridin-4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento de traumatismos cranianos PT2146713E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0702852A FR2915099B1 (fr)	2007-04-19	2007-04-19	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens

Publications (1)

Publication Number	Publication Date
PT2146713E true PT2146713E (pt)	2012-02-07

Family

ID=38819821

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT08787960T PT2146713E (pt)	2007-04-19	2008-04-16	Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4- piridin-4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento de traumatismos cranianos

Country Status (34)

Country	Link
US (1)	US9393236B2 (sr)
EP (1)	EP2146713B1 (sr)
JP (1)	JP5386476B2 (sr)
KR (1)	KR101460828B1 (sr)
CN (1)	CN101663036B (sr)
AR (1)	AR066105A1 (sr)
AT (1)	ATE532513T1 (sr)
AU (1)	AU2008257319B2 (sr)
BR (1)	BRPI0810423A2 (sr)
CA (1)	CA2684171C (sr)
CL (1)	CL2008001135A1 (sr)
CO (1)	CO6140028A2 (sr)
CY (1)	CY1112282T1 (sr)
DK (1)	DK2146713T3 (sr)
EA (1)	EA015503B1 (sr)
ES (1)	ES2376023T3 (sr)
FR (1)	FR2915099B1 (sr)
HR (1)	HRP20120130T1 (sr)
IL (1)	IL201447A (sr)
JO (1)	JO2861B1 (sr)
MA (1)	MA31368B1 (sr)
ME (2)	ME00938B (sr)
MX (1)	MX2009011214A (sr)
MY (1)	MY147207A (sr)
NZ (1)	NZ580484A (sr)
PA (1)	PA8776701A1 (sr)
PL (1)	PL2146713T3 (sr)
PT (1)	PT2146713E (sr)
PY (1)	PY08013254A (sr)
RS (1)	RS52130B (sr)
SI (1)	SI2146713T1 (sr)
TW (1)	TWI423800B (sr)
UY (1)	UY31034A1 (sr)
WO (1)	WO2008145838A2 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112015011849A2 (pt) *	2012-11-28	2017-07-11	Sanofi Sa	método de preparação de formas de cristal de 4 (ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metoxipiridina-2-carboxamida e formas de cristal da mesma
WO2025079694A1 (ja) *	2023-10-12	2025-04-17	株式会社メドレックス	経皮吸収組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1273326A (en) *	1917-08-22	1918-07-23	George H Bugenhagen	Transmission mechanism.
US4193926A (en)	1974-03-20	1980-03-18	Schering Aktiengesellschaft	4-(Polyalkoxy phenyl)-2-pyrrolidones
JP3775685B2 (ja) *	1993-07-28	2006-05-17	ローン−プーラン・ロレ・リミテツド	Ｐｄｅ▲ｉｖ▼およびｔｎｆ抑制剤としての化合物
GB9401460D0 (en) *	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
GB9507297D0 (en) *	1995-04-07	1995-05-31	Rh Ne Poulenc Rorer Limited	New composition of matter
US6177077B1 (en)	1999-02-24	2001-01-23	Edward L. Tobinick	TNT inhibitors for the treatment of neurological disorders
JP2003513006A (ja) *	1999-06-07	2003-04-08	ワーナー−ランバート・カンパニー	三環性鎮痛薬
PT1244649E (pt) *	1999-12-23	2005-06-30	Icos Corp	Inibidores de fosfodiesterase especificos de mfa ciclica
EP1370211A4 (en) *	2001-03-02	2005-02-09	Bristol Myers Squibb Co	SIMULTANEOUS ADMINISTRATION OF MELANOCORTIN RECEPTOR AGONISTS AND A PHOSPHODIESTERASE HEMMER FOR THE TREATMENT OF DISEASES RELATED TO CYCLIC AMP
AU2003281219A1 (en)	2002-07-02	2004-01-23	Bernard Cote	Di-aryl-substituted-ethane pyridone pde4 inhibitors
WO2004067006A1 (en) *	2003-01-27	2004-08-12	Pharmacia Corporation	Combination of a pde iv inhibitor and a tnf-alpha antagonist
MXPA06003949A (es)	2003-10-07	2006-06-27	Renovis Inc	Compuestos amida como ligandos del canal de ion y su uso.
JP2008543781A (ja) *	2005-06-10	2008-12-04	メモリー・ファーマシューティカルズ・コーポレイション	ホスフオジエステラーゼ４阻害剤
US20070021451A1 (en)	2005-07-20	2007-01-25	Hamamatsu University School Of Medicine	Method for preventing or treating neurologic damage after spinal cord injury
FR2915098B1 (fr)	2007-04-19	2009-06-05	Sanofi Aventis Sa	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

2007
- 2007-04-19 FR FR0702852A patent/FR2915099B1/fr not_active Expired - Fee Related
2008
- 2008-04-15 PA PA20088776701A patent/PA8776701A1/es unknown
- 2008-04-16 DK DK08787960.7T patent/DK2146713T3/da active
- 2008-04-16 PL PL08787960T patent/PL2146713T3/pl unknown
- 2008-04-16 WO PCT/FR2008/000531 patent/WO2008145838A2/fr not_active Ceased
- 2008-04-16 MX MX2009011214A patent/MX2009011214A/es active IP Right Grant
- 2008-04-16 SI SI200830535T patent/SI2146713T1/sl unknown
- 2008-04-16 CN CN2008800127185A patent/CN101663036B/zh not_active Expired - Fee Related
- 2008-04-16 AU AU2008257319A patent/AU2008257319B2/en not_active Ceased
- 2008-04-16 MY MYPI20094365A patent/MY147207A/en unknown
- 2008-04-16 KR KR1020097021592A patent/KR101460828B1/ko not_active Expired - Fee Related
- 2008-04-16 NZ NZ580484A patent/NZ580484A/en not_active IP Right Cessation
- 2008-04-16 EP EP08787960A patent/EP2146713B1/fr active Active
- 2008-04-16 PT PT08787960T patent/PT2146713E/pt unknown
- 2008-04-16 JP JP2010503546A patent/JP5386476B2/ja not_active Expired - Fee Related
- 2008-04-16 RS RS20120041A patent/RS52130B/sr unknown
- 2008-04-16 ES ES08787960T patent/ES2376023T3/es active Active
- 2008-04-16 BR BRPI0810423-9A2A patent/BRPI0810423A2/pt not_active IP Right Cessation
- 2008-04-16 ME MEP-2009-306A patent/ME00938B/me unknown
- 2008-04-16 AT AT08787960T patent/ATE532513T1/de active
- 2008-04-16 HR HR20120130T patent/HRP20120130T1/hr unknown
- 2008-04-16 ME MEP-2012-15A patent/ME01273B/me unknown
- 2008-04-16 EA EA200970968A patent/EA015503B1/ru not_active IP Right Cessation
- 2008-04-16 CA CA2684171A patent/CA2684171C/fr not_active Expired - Fee Related
- 2008-04-17 JO JO2008184A patent/JO2861B1/en active
- 2008-04-17 TW TW097113999A patent/TWI423800B/zh not_active IP Right Cessation
- 2008-04-18 AR ARP080101599A patent/AR066105A1/es unknown
- 2008-04-18 UY UY31034A patent/UY31034A1/es not_active Application Discontinuation
- 2008-04-18 PY PY200808013254A patent/PY08013254A/es unknown
- 2008-04-18 CL CL2008001135A patent/CL2008001135A1/es unknown
2009
- 2009-10-05 US US12/573,322 patent/US9393236B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201447A patent/IL201447A/en not_active IP Right Cessation
- 2009-10-19 CO CO09116642A patent/CO6140028A2/es unknown
- 2009-11-10 MA MA32334A patent/MA31368B1/fr unknown
2012
- 2012-01-26 CY CY20121100094T patent/CY1112282T1/el unknown

Also Published As

Publication number	Publication date
EA015503B1 (ru)	2011-08-30
US20100130553A1 (en)	2010-05-27
PA8776701A1 (es)	2008-11-19
WO2008145838A3 (fr)	2009-03-26
CN101663036B (zh)	2012-06-20
CA2684171C (fr)	2015-12-01
RS52130B (sr)	2012-08-31
TWI423800B (zh)	2014-01-21
EP2146713A2 (fr)	2010-01-27
ATE532513T1 (de)	2011-11-15
ES2376023T3 (es)	2012-03-08
JP5386476B2 (ja)	2014-01-15
KR101460828B1 (ko)	2014-11-11
HK1141724A1 (en)	2010-11-19
MX2009011214A (es)	2009-11-02
AU2008257319B2 (en)	2013-07-25
AR066105A1 (es)	2009-07-22
ME00938B (me)	2012-06-20
CN101663036A (zh)	2010-03-03
ME01273B (me)	2013-06-20
JP2010524903A (ja)	2010-07-22
IL201447A (en)	2013-07-31
PL2146713T3 (pl)	2012-04-30
NZ580484A (en)	2011-06-30
CA2684171A1 (fr)	2008-12-04
BRPI0810423A2 (pt)	2014-10-14
EP2146713B1 (fr)	2011-11-09
FR2915099B1 (fr)	2009-06-05
AU2008257319A1 (en)	2008-12-04
PY08013254A (es)	2013-07-01
WO2008145838A2 (fr)	2008-12-04
FR2915099A1 (fr)	2008-10-24
IL201447A0 (en)	2010-05-31
MA31368B1 (fr)	2010-05-03
MY147207A (en)	2012-11-14
US9393236B2 (en)	2016-07-19
KR20090130058A (ko)	2009-12-17
SI2146713T1 (sl)	2012-03-30
EA200970968A1 (ru)	2010-02-26
CL2008001135A1 (es)	2009-01-16
TW200914009A (en)	2009-04-01
CO6140028A2 (es)	2010-03-19
CY1112282T1 (el)	2015-12-09
DK2146713T3 (da)	2012-03-05
HRP20120130T1 (hr)	2012-03-31
JO2861B1 (en)	2015-03-15
UY31034A1 (es)	2008-11-28

Publication	Publication Date	Title
US20190192525A1 (en)	2019-06-27	Apilimod compositions and methods for using same
BR112015010271B1 (pt)	2020-04-22	produto de comicronização, processo para o preparo de um produto de comicronização, composição farmacêutica e seus usos
JP5386477B2 (ja)	2014-01-15	脊髄損傷を治療するための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用
PT2146713E (pt)	2012-02-07	Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4- piridin-4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento de traumatismos cranianos
TWI439269B (zh)	2014-06-01	４－環丙基甲氧基－ｎ－（３，５－二氯－１－氧離子基吡啶－４－基）－５－（甲氧基）吡啶－２－甲醯胺於製備用於治療與帕金森氏病有關之運動障礙症的藥物之用途
ES2326078T3 (es)	2009-09-30	Medicamento destinado al sindrome de la disfuncion de integracion.
BRPI0709967A2 (pt)	2011-08-02	composição farmacêutica que compreende a combinação de um sal de ketorolaco e vitaminas do complexo b para o tratamento de nevralgias
EP3556363B1 (en)	2024-03-06	Use of carbamate compound for prevention, alleviation or treatment of pruritus
CN102178676B (zh)	2012-07-25	一种治疗脑胶质瘤的药物组合物
HK1141724B (en)	2013-02-01	Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
HK40015213A (en)	2020-08-28	Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder